Gregory Robt Harriman MD FACP
Adult Clinical & Laboratory Immunology, Infectious Disease
Partner, Chief Investment Officer BioAdvance
Join to View Full Profile
231 Iron Works WayWayne, PA 19087
Phone+1 610-246-9822
Dr. Harriman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1985 - 1988
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1983 - 1985
Sutter Health/California Pacific Medical CenterInternship, Internal Medicine, 1982 - 1983
Scripps ClinicPost Doc, Immunology, 1981 - 1982
University of California San Diego School of MedicineClass of 1981
Certifications & Licensure
PA State Medical License 2009 - 2026
TX State Medical License 1992 - 1996
MD State Medical License 1990 - 1992
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Clinical & Laboratory Immunology
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 2 citationsImmunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus.Yongxin Zhang, Susan Pacheco, Catherine L Acuna, Kirsten C Switzer, Ying Wang
Immunology. 2002-03-01 - 180 citationsIgA production without mu or delta chain expression in developing B cells.Andrew J. Macpherson, Alain Lamarre, Kathy D. McCoy, Gregory R. Harriman, Bernard Odermatt
Nature Immunology. 2001-07-01 - 821 citationsA Primitive T Cell-Independent Mechanism of Intestinal Mucosal IgA Responses to Commensal BacteriaAndrew J. Macpherson, Dominique Gatto, Elizabeth Sainsbury, Gregory R. Harriman, Hans Hengartner
Science. 2000-06-23
Press Mentions
Diagnostic Startup Senzo Raised $2M from Local Investors to Bring Its at-Home COVID-19 Test to MarketJuly 21st, 2022
Grant Support
- Regulation Of IGA B Cell Isotype DifferentiationNational Institute Of Allergy And Infectious Diseases1995
- Strategies For Induction Of Mucosal Immunity To HIVNational Institute Of Allergy And Infectious Diseases1992–1994
- Mouse Model Of IGA Deficiency Using Gene TargetingNational Center For Research Resources1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
